Buy AMB-FUBINACA (FUB-AMB)
AMB-FUBINACA (also known as FUB-AMB and MMB-FUBINACA) is an indazole-based synthetic cannabinoid that is a potent agonist for the cannabinoid receptors, with Ki values of 10.04 nM at CB1 and 0.786 nM at CB2 and EC50 values of 0.5433 nM at CB1 and 0.1278 nM at CB2, and has been sold online as a designer drug. It was originally develop by Pfizer which describe the compound in a patent in 2009, but was later abandon and never tested on humans.
As far as the synthetic cannabinoids go, FUB-AMB is one of the more potent ones. So, proper laboratory safety procedures should be use . Research experiments involving FUB-AMB typically generate findings of full-body high, euphoria, elevated mood, and relaxation.
AMB-FUBINACA for sale is a synthetic cannabinoid which is also called MMB-FUBINACA or FUB-AMB. Being a popular indazole-base compound, it is offer on the web as one of present-day designer drugs. Over the past time the run on such agents is on rise. FUB-AMB is getting more popular due to the fact it combines some basic characteristics of 5-Fluouro AMB and AB-PINACA. The drug’s molecule features a methoxy group, which is tack instead of a primary amine.
All AMB series of agents is consider as derivatives of the AB-INACA – the earliest series of synthetic cannabinoids. However, AMB series do differ from AB-INACA ones. primary amine groups are replace by methoxy ones. The mentioned replacement can lead to 2-amino-3-methylbutanoic acid – a moiety structural based of amino acid.
Pfizer was working on developing a synthetic cannabinoid to treat pain in cancer patients, as synthetic
cannabinoids may be more likely to ease pain without the effects of THC (i.e., producing a high in the user).
During the clinical trials, Pfizer discontinued their research into properties of the drug. Currently, there are no
approved medical uses in humans for AMB-FUBINACA or its related compounds.